Menstrual cycle influences on cue-induced smoking cravings and heart rate variability.
Journal
Behavioural pharmacology
ISSN: 1473-5849
Titre abrégé: Behav Pharmacol
Pays: England
ID NLM: 9013016
Informations de publication
Date de publication:
01 08 2023
01 08 2023
Historique:
medline:
6
7
2023
pubmed:
4
7
2023
entrez:
4
7
2023
Statut:
ppublish
Résumé
Women experience greater difficulties in quitting smoking than men, though the hormonal factors contributing to this sex difference remain to be clarified. The current study aimed to examine menstrual cycle effects on smoking cue-induced cravings as well as examine dynamic reproductive hormone change as a potential mediator underlying any cycle effects observed. Twenty-one women who smoke underwent two laboratory sessions - one in the mid-follicular phase and the other in the late luteal phase - involving an in-vivo smoking cue task, administered before and after exposure to a psychosocial laboratory stressor. Heart rate variability (HRV) and subjective smoking cravings were assessed in response to the cue task. The degree of change in the urinary metabolites of estradiol and progesterone from 2 days before to the day of each laboratory session was measured. Results revealed that both before and following exposure to psychosocial stress, highly nicotine-dependent women exhibited smaller cue-induced increases in HRV relative to the follicular phase. In contrast, less nicotine-dependent women exhibit an increase in HRV in both menstrual cycle phases. Results furthermore suggest that menstrual cycle effects seen in highly nicotine-dependent women are driven by the decline in estradiol and progesterone occurring in the late luteal phase. Though limited by a small sample size, this study suggests that withdrawal from reproductive hormones in the late luteal phase may alter highly nicotine-dependent women's physiological response to smoking cues, which may reflect greater difficulty resisting temptation. These findings may provide some insight regarding women's greater difficulty in maintaining abstinence after quitting smoking.
Identifiants
pubmed: 37401397
doi: 10.1097/FBP.0000000000000734
pii: 00008877-990000000-00045
doi:
Substances chimiques
Nicotine
6M3C89ZY6R
Progesterone
4G7DS2Q64Y
Estradiol
4TI98Z838E
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
287-298Informations de copyright
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Références
Al’Absi M (2011). Stress and addiction: biological and psychological mechanisms. Elsevier.
Allen AP, Kennedy PJ, Cryan JF, Dinan TG, Clarke G (2014). Biological and psychological markers of stress in humans: focus on the trier social stress test. Neurosci Biobehav Rev 38:94–124.
Becker JB, McClellan M, Reed BG (2016). Sociocultural context for sex differences in addiction. Addict Biol 21:1052–1059.
Bitran D, Shiekh M, McLeod M (1995). Anxiolytic effect of progesterone is mediated by the neurosteroid allopregnanolone at brain GABAA receptors. J Neuroendocrinol 7:171–177.
Carpenter MJ, Saladin ME, DeSantis S, Gray KM, LaRowe SD, Upadhyaya HP (2009). Laboratory-based, cue-elicited craving and cue reactivity as predictors of naturally occurring smoking behavior. Addict Behav 34:536–541.
Childs E, De Wit H (2010). Effects of acute psychosocial stress on cigarette craving and smoking. Nicotine Tob Res 12:449–453.
Claus ED, Blaine SK, Filbey FM, Mayer AR, Hutchison KE (2013). Association between nicotine dependence severity, BOLD response to smoking cues, and functional connectivity. Neuropsychopharmacology 38:2363–2372.
Colamussi L, Bovbjerg DH, Erblich J (2007). Stress-and cue-induced cigarette craving: effects of a family history of smoking. Drug Alcohol Depend 88:251–258.
Conklin CA, Vella EJ, Joyce CJ, Salkeld RP, Perkins KA, Parzynski CS (2015). Examining the relationship between cue-induced craving and actual smoking. Exp Clin Psychopharmacol 23:90–96.
Doran N (2014). Sex differences in smoking cue reactivity: craving, negative affect, and preference for immediate smoking. Am J Addict 23:211–217.
Ethier AR, McKinney TL, Tottenham LS, Gordon JL (2021). The effect of reproductive hormones on women’s daily smoking across the menstrual cycle. Biol Sex Diff 12:1–10.
Fattore L, Altea S, Fratta W (2008). Sex differences in drug addiction: a review of animal and human studies. Women’s Health 4:51–65.
Field M, Duka T (2004). Cue reactivity in smokers: the effects of perceived cigarette availability and gender. Pharmacol Biochem Behav 78:647–652.
Fox HC, Sinha R (2009). Sex differences in drug-related stress-system changes: implications for treatment in substance-abusing women. Harv Rev Psychiatry 17:103–119.
Franklin TR, Napier K, Ehrman R, Gariti P, O’Brien CP, Childress AR (2004). Retrospective study: influence of menstrual cycle on cue-induced cigarette craving. Nicotine Tob Res 6:171–175.
Galea LA, Wide JK, Barr AM (2001). Estradiol alleviates depressive-like symptoms in a novel animal model of post-partum depression. Behav Brain Res 122:1–9. https://www.ncbi.nlm.nih.gov/pubmed/11287071 .
Gallo MA, Smith SS (1993). Progesterone withdrawal decreases latency to and increases duration of electrified prod burial: a possible rat model of PMS anxiety. Pharmacol Biochem Behav 46:897–904. https://www.ncbi.nlm.nih.gov/pubmed/7906038 .
Genazzani A, Petraglia F, Bernardi F, Casarosa E, Salvestroni C, Tonetti A, et al. (1998). Circulating levels of allopregnanolone in humans: gender, age, and endocrine influences. J Clin Endocrinol Metab 83:2099–2103.
Goeders NE (2003). The impact of stress on addiction. Eur Neuropsychopharmacol 13:435–441.
Gordon JL, Girdler SS (2014). Mechanisms underlying hemodynamic and neuroendocrine stress reactivity at different phases of the menstrual cycle. Psychophysiology 51:309–318.
Gordon JL, Rubinow DR, Eisenlohr-Moul TA, Leserman J, Girdler SS (2016a). Estradiol variability, stressful life events, and the emergence of depressive symptomatology during the menopausal transition. Menopause 23:257–266.
Gordon JL, Rubinow DR, Thurston RC, Paulson J, Schmidt PJ, Girdler SS (2016b). Cardiovascular, hemodynamic, neuroendocrine, and inflammatory markers in women with and without vasomotor symptoms. Menopause 23:1189–1198.
Gordon JL, Peltier A, Grummisch J, Sykes Tottenham L (2019). Estradiol fluctuation, sensitivity to stress, and depressive symptoms in the menopause transition: a pilot study. Front Psychol 10:1319.
Gray KM, DeSantis SM, Carpenter MJ, Saladin ME, LaRowe SD, Upadhyaya HP (2010). Menstrual cycle and cue reactivity in women smokers. Nicotine Tob Res 12:174–178.
Guzik P, Piekos C, Pierog O, Fenech N, Krauze T, Piskorski J, et al. (2018). Classic electrocardiogram-based and mobile technology derived approaches to heart rate variability are not equivalent. Int J Cardiol 258:154–156.
Hartwell EE, Ray LA (2013). Sex moderates stress reactivity in heavy drinkers. Addict Behav 38:2643–2646.
Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO (1991). The Fagerström test for nicotine dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 86:1119–1127.
Heinsbroek RP, Van Haaren F, Feenstra MG, Van Galen H, Boer G, Van de Poll NE (1990). Sex differences in the effects of inescapable footshock on central catecholaminergic and serotonergic activity. Pharmacol Biochem Behav 37:539–550.
Ingjaldsson JT, Laberg JC, Thayer JF (2003). Reduced heart rate variability in chronic alcohol abuse: relationship with negative mood, chronic thought suppression, and compulsive drinking. Biol Psychiatry 54:1427–1436.
Kirschbaum C, Pirke K-M, Hellhammer DH (1993). The ‘Trier Social Stress Test’ – a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology 28:76–81.
Kirschbaum C, Kudielka BM, Gaab J, Schommer NC, Hellhammer DH (1999). Impact of gender, menstrual cycle phase, and oral contraceptives on the activity of the hypothalamus-pituitary-adrenal axis. Psychosom Med 61:154–162.
Kosten TA, Miserendino MJ, Kehoe P (2000). Enhanced acquisition of cocaine self-administration in adult rats with neonatal isolation stress experience. Brain Res 875:44–50.
Lahiri MK, Kannankeril PJ, Goldberger JJ (2008). Assessment of autonomic function in cardiovascular disease: physiological basis and prognostic implications. J Am Coll Cardiol 51:1725–1733.
LaRowe SD, Saladin ME, Carpenter MJ, Upadhyaya HP (2007). Reactivity to nicotine cues over repeated cue reactivity sessions. Addict Behav 32:2888–2899.
Lustyk MKB, Olson KC, Gerrish WG, Holder A, Widman L (2010). Psychophysiological and neuroendocrine responses to laboratory stressors in women: implications of menstrual cycle phase and stressor type. Biol Psychol 83:84–92.
Mathieu-Kia A, Kellogg S, Butelman E, Kreek M (2002). Nicotine addiction: insights from recent animal studies. Psychopharmacology (Berl) 162:102–118.
McClernon FJ, Kozink RV, Rose JE (2008). Individual differences in nicotine dependence, withdrawal symptoms, and sex predict transient fMRI-BOLD responses to smoking cues. Neuropsychopharmacology 33:2148–2157.
McGrath E, Jones A, Field M (2016). Acute stress increases ad-libitum alcohol consumption in heavy drinkers, but not through impaired inhibitory control. Psychopharmacology (Berl) 233:1227–1234.
Morrow AL, Suzdak PD, Paul SM (1987). Steroid hormone metabolites potentiate GABA receptor-mediated chloride ion flux with nanomolar potency. Eur J Pharmacol 142:483–485.
Niaura R, Shadel WG, Abrams DB, Monti PM, Rohsenow DJ, Sirota A (1998). Individual differences in cue reactivity among smokers trying to quit: effects of gender and cue type. Addict Behav 23:209–224.
O’Connor KA, Brindle E, Holman DJ, Klein NA, Soules MR, Campbell KL, et al. (2003). Urinary estrone conjugate and pregnanediol 3-glucuronide enzyme immunoassays for population research. Clin Chem 49:1139–1148.
Perkins KA, Donny E, Caggiula AR (1999). Sex differences in nicotine effects and self-administration: review of human and animal evidence. Nicotine Tob Res 1:301–315.
Piazza PV, Le Moal M (1998). The role of stress in drug self-administration. Trends Pharmacol Sci 19:67–74.
Pluchino N, Luisi M, Lenzi E, Centofanti M, Begliuomini S, Freschi L, et al. (2006). Progesterone and progestins: effects on brain, allopregnanolone and β-endorphin. J Steroid Biochem Mol Biol 102:205–213.
Radloff LS (1977). The CES-D scale: a self-report depression scale for research in the general population. Appli Psycholo Measurem 1:385–401.
Reid JL, Hammond D, Rynard VL, Burkhalter R (2014). Tobacco use in Canada: patterns and trends. University of Waterloo, Propel Centre for Population Health Impact.
Rodriguez-Landa JF, Contreras CM, Bernal-Morales B, Gutierrez-Garcia AG, Saavedra M (2007). Allopregnanolone reduces immobility in the forced swimming test and increases the firing rate of lateral septal neurons through actions on the GABAA receptor in the rat. J Psychopharmacol 21:76–84.
Saladin ME, Gray KM, Carpenter MJ, LaRowe SD, DeSantis SM, Upadhyaya HP (2012). Gender differences in craving and cue reactivity to smoking and negative affect/stress cues. Am J Addict 21:210–220.
Scheel-Krüger J (1986). Dopamine-GABA interactions: evidence that GABA transmits, modulates and mediates dopaminergic functions in the basal ganglia and the limbic system. Acta Neurol Scand 73(Suppl No 107):54.
Schiller CE, Saladin ME, Gray KM, Hartwell KJ, Carpenter MJ (2012). Association between ovarian hormones and smoking behavior in women. Exp Clin Psychopharmacol 20:251–257.
Schmidt PJ, Martinez PE, Nieman LK, Koziol DE, Thompson KD, Schenkel L, et al. (2017). Premenstrual dysphoric disorder symptoms following ovarian suppression: triggered by change in ovarian steroid levels but not continuous stable levels. Am J Psychiatry 174:980–989.
Segerstrom SC, Nes LS (2007). Heart rate variability reflects self-regulatory strength, effort, and fatigue. Psychol Sci 18:275–281.
Shaffer F, Ginsberg JP (2017). An overview of heart rate variability metrics and norms. Front Public Health 5:258.
Shaham Y, Shalev U, Lu L, de Wit H, Stewart J (2003). The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology (Berl) 168:3–20.
Snijders TAB, Bosker RJ (1999). Multilevel analysis: an introduction to basic and advanced multilevel modeling. Sage.
Smith PH, Bessette AJ, Weinberger AH, Sheffer CE, McKee SA (2016). Sex/gender differences in smoking cessation: a review. Prev Med 92:135–140.
Tarvainen MP, Niskanen J-P, Lipponen JA, Ranta-Aho PO, Karjalainen PA (2014). Kubios HRV – heart rate variability analysis software. Comput Methods Programs Biomed 113:210–220.
Teusch R (2001). Substance abuse as a symptom of childhood sexual abuse. Psychiatr Serv 52:1530–1532.
Tiffany ST, Drobes DJ (1991). The development and initial validation of a questionnaire on smoking urges. Br J Addict 86:1467–1476.
Triffleman EG, Marmar CR, Delucchi KL, Ronfeldt H (1995). Childhood trauma and posttraumatic stress disorder in substance abuse inpatients. J Nerv Ment Dis 183:172–176.
Weinberger AH, Smith PH, Allen SS, Cosgrove KP, Saladin ME, Gray KM, et al. (2015). Systematic and meta-analytic review of research examining the impact of menstrual cycle phase and ovarian hormones on smoking and cessation. Nicotine Tob Res 17:407–421.